This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here.Ozempic broke out in a big way this year. By the time Jimmy Kimmel made a crack at the Oscars about the medication, bringing it a new surge of national attention, diabetes and obesity drugs that suppress appetite had been on the rise for months.

Within the first five seconds of a recent Ozempic commercial, a sky-blue injector pen tumbles toward the viewer, encircled by a big red O. Obesity drugs have become so closely associated with injections that the two are virtually synonymous. Like Ozempic, whose name is now a catchall term for obesity drugs, Wegovy and Zepbound come packaged in Sharpie-like injection pens that patients self-administer once a week.

This is an edition of Time-Travel Thursdays, a journey through The Atlantic’s archives to contextualize the present, surface delightful treasures, and examine the American idea. Sign up here.Not so long ago, an Atlantic writer set out to defend the former president, a notorious liar with a knack for escaping jams—and one who derived an unseemly joy from impunity. Hand-wringing about this sort of behavior, Roy Blount Jr.

In the spring of 1994, the top executives of the seven largest tobacco companies testified under oath before Congress that nicotine is not addictive. Nearly 30 years later, Americans remember their laughable claims, their callous indifference, their lawyerly inability to speak plainly, and the general sense that they did not regard themselves as part of a shared American community. Those pampered executives, behaving with such Olympian detachment, put the pejorative big in Big Tobacco.

There is a tension at the heart of ChatGPT that may soon snap. Does the technology expand our world or constrain it? Which is to say, do AI-powered chatbots open new doors to learning and discovery, or do they instead risk siloing off information and leaving us stuck with unreliable access to truth?Earlier today, OpenAI, the maker of ChatGPT, announced a partnership with the media conglomerate Axel Springer that seems to get us closer to an answer.

This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here.American legislators demand scenarios for war termination that neither Ukraine nor the Biden administration can provide, because critics of Ukraine aid are asking the wrong questions.

When you’re shopping around for something on Amazon, you’re probably hoping to end up with a product that is good enough. Many of the site’s stock images and product descriptions have an unpredictable relationship to the objects you’ll actually receive; to guard against surprises, you frequently need to peruse the ratings and reviews left by the shoppers who came before you.

This morning in Dubai, after a long night of consultations, the world struck a deal that will guide countries’ commitments to fixing climate change. For the first time in the nearly 30 years of the Conference of Parties, a COP document managed to directly address reducing fossil fuels. The text “calls on parties” to transition “away from fossil fuels in energy systems.